Literature DB >> 29956210

Microbiota, Obesity and NAFLD.

Louis H S Lau1, Sunny H Wong2.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an increasingly important cause of chronic liver disease globally. Similar to metabolic syndrome and obesity, NAFLD is associated with alternations in the gut microbiota and its related biological pathways. While the exact pathophysiology of NAFLD remains largely unknown, changes in intestinal inflammation, gut permeability, energy harvest, anaerobic fermentation and insulin resistance have been described. In this chapter, we review the relationship between the gut microbiota, obesity and NAFLD, and highlight potential ways to modify the gut microbiota to help managing NAFLD patients.

Entities:  

Keywords:  Energy harvest; Fatty liver; Gut permeability; Insulin resistance; Intestinal inflammation; Microbiota

Mesh:

Year:  2018        PMID: 29956210     DOI: 10.1007/978-981-10-8684-7_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  19 in total

Review 1.  Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.

Authors:  Natalia Vallianou; Theodora Stratigou; Gerasimos Socrates Christodoulatos; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2019-09

2.  Bile acid metabolism and liver fibrosis following treatment with bifid triple viable capsules in nonalcoholic fatty liver disease.

Authors:  Yuqing Zhou; Wen Lu; Guorong Yang; Yifeng Chen; Jiwei Cao; Chunli Zhou
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

3.  Encoding with a fluorescence-activating and absorption-shifting tag generates living bacterial probes for mammalian microbiota imaging.

Authors:  Zhenping Cao; Lu Wang; Rui Liu; Sisi Lin; Feng Wu; Jinyao Liu
Journal:  Mater Today Bio       Date:  2022-06-06

4.  Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.

Authors:  Lanfeng Xue; Zhiliang Deng; Wenhui Luo; Xingxiang He; Yu Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-07-04       Impact factor: 6.073

5.  Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis.

Authors:  Antonietta Gerarda Gravina; Mario Romeo; Raffaele Pellegrino; Concetta Tuccillo; Alessandro Federico; Carmelina Loguercio
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

6.  Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics.

Authors:  Larissa S Celiberto; Roseli Aparecida Pinto; Elizeu Antonio Rossi; Bruce A Vallance; Daniela C U Cavallini
Journal:  Nutrients       Date:  2018-11-05       Impact factor: 5.717

7.  Potential role of phytochemicals in metabolic syndrome prevention and therapy.

Authors:  Francesco Francini-Pesenti; Paolo Spinella; Lorenzo A Calò
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-01       Impact factor: 3.168

8.  Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment.

Authors:  Zhenping Cao; Xinyue Wang; Yan Pang; Shanshan Cheng; Jinyao Liu
Journal:  Nat Commun       Date:  2019-12-19       Impact factor: 14.919

9.  Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy.

Authors:  Xueling Xu; Huifang Wang; Dandan Guo; Xiaofei Man; Jun Liu; Junying Li; Congjuan Luo; Ming Zhang; Li Zhen; Xuemei Liu
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

Review 10.  Role of Overweight and Obesity in Gastrointestinal Disease.

Authors:  Sara Emerenziani; Michele Pier Luca Guarino; Laura Maria Trillo Asensio; Annamaria Altomare; Mentore Ribolsi; Paola Balestrieri; Michele Cicala
Journal:  Nutrients       Date:  2019-12-31       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.